1. Home
  2. CDNA vs OGN Comparison

CDNA vs OGN Comparison

Compare CDNA & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$49.77

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.78

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
OGN
Founded
1998
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
CDNA
OGN
Price
$49.77
$13.78
Analyst Decision
Buy
Hold
Analyst Count
6
5
Target Price
$28.00
$11.40
AVG Volume (30 Days)
970.3K
3.0M
Earning Date
04-28-2026
05-07-2026
Dividend Yield
N/A
0.60%
EPS Growth
N/A
N/A
EPS
2.13
0.95
Revenue
$48,324,000.00
$6,216,000,000.00
Revenue This Year
$16.01
$0.45
Revenue Next Year
$11.31
$1.67
P/E Ratio
$22.94
$14.49
Revenue Growth
18.93
N/A
52 Week Low
$13.39
$5.69
52 Week High
$53.67
$13.79

Technical Indicators

Market Signals
Indicator
CDNA
OGN
Relative Strength Index (RSI) 59.63 74.71
Support Level $44.80 $13.46
Resistance Level $49.76 N/A
Average True Range (ATR) 2.51 0.03
MACD -0.51 -0.00
Stochastic Oscillator 45.88 91.67

Price Performance

Historical Comparison
CDNA
OGN

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: